Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
3
×
life sciences
national blog main
national top stories
biotech
clinical trials
national
san francisco blog main
san francisco top stories
alder biopharmaceutical
allergan
allosteric
american academy of neurology
amgen
atlas venture
atogepant
atopic dermatitis
autoimmune disorders
biohaven
bob azelby
boston
botox
boulder/denver blog main
boulder/denver top stories
brace pharma
brian abrahams
calcitonin gene-related peptide
cancer
cleva pharma
crispr
crispr therapeutics
crispr-cas9
deals
detroit blog main
detroit top stories
drug discovery
drugs
dupilumab
editas
What
new
3
×
potential
3
×
address
adds
ago
allosteric
approval
arguments
big
cancer
cas
cells
class
clinic
commercialized
companies
competitors
crispr
decades
defect
disease
drive
drug
drugs
edited
editing
elusive
fda
fears
flag
gene
genetic
guardian
hotspot
human
known
lab
make
malfunction
medicine
Language
unset
Current search:
new
×
potential
×
" boston top stories "
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
